Literature DB >> 9048730

Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist.

R Voltz, M Hartmann, S Spuler, A Scheller, N Mai, R Hohlfeld, T Yousry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9048730      PMCID： PMC486741          DOI： 10.1136/jnnp.62.2.200-b

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease.

Authors:  H J Gruss; G Dölken; M A Brach; R Mertelsmann; F Herrmann
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

Review 2.  Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  T Olsson
Journal:  Immunol Rev       Date:  1995-04       Impact factor: 12.988

3.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Authors:  C J Fisher; J F Dhainaut; S M Opal; J P Pribble; R A Balk; G J Slotman; T J Iberti; E C Rackow; M J Shapiro; R L Greenman
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

Review 4.  Interleukin-1 receptor antagonist.

Authors:  W P Arend
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543
  4 in total
  4 in total

1.  Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1β.

Authors:  Paul R Lee; Tory P Johnson; Sharmilee Gnanapavan; Gavin Giovannoni; Tongguang Wang; Joseph P Steiner; Marie Medynets; Mark J Vaal; Valerie Gartner; Avindra Nath
Journal:  J Neuroinflammation       Date:  2017-06-27       Impact factor: 8.322

2.  NLRP3 Inflammasome and MS/EAE.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Autoimmune Dis       Date:  2013-01-08

3.  Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis.

Authors:  Hans M Schrijver; Jaco van As; J Bart A Crusius; Christien D Dijkstra; Bernard M J Uitdehaag
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

4.  Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity.

Authors:  Trygve Holmøy; Kristin Ingeleiv Løken-Amsrud; Søren Jacob Bakke; Antonie G Beiske; Kristian S Bjerve; Harald Hovdal; Finn Lilleås; Rune Midgard; Tom Pedersen; Jutrate Saltytė Benth; Oivind Torkildsen; Stig Wergeland; Kjell-Morten Myhr; Annika E Michelsen; Pål Aukrust; Thor Ueland
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.